Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

Cited In for PubMed (Select 15048890)

1.

Long noncoding RNAs(lncRNAs) and the molecular hallmarks of aging.

Grammatikakis I, Panda AC, Abdelmohsen K, Gorospe M.

Aging (Albany NY). 2014 Dec;6(12):992-1009.

2.

Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system.

McKeon JE, Sha D, Li L, Chin LS.

Cell Mol Life Sci. 2015 May;72(9):1811-24. doi: 10.1007/s00018-014-1781-2. Epub 2014 Nov 18.

PMID:
25403879
3.

Genome-wide distribution of Auts2 binding localizes with active neurodevelopmental genes.

Oksenberg N, Haliburton GD, Eckalbar WL, Oren I, Nishizaki S, Murphy K, Pollard KS, Birnbaum RY, Ahituv N.

Transl Psychiatry. 2014 Sep 2;4:e431. doi: 10.1038/tp.2014.78.

4.

Loss of UCHL1 promotes age-related degenerative changes in the enteric nervous system.

Coulombe J, Gamage P, Gray MT, Zhang M, Tang MY, Woulfe J, Saffrey MJ, Gray DA.

Front Aging Neurosci. 2014 Jun 19;6:129. doi: 10.3389/fnagi.2014.00129. eCollection 2014.

5.
6.

RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis.

Heman-Ackah SM, Hallegger M, Rao MS, Wood MJ.

Front Mol Neurosci. 2013 Nov 20;6:40. doi: 10.3389/fnmol.2013.00040. Review.

7.

A micro-silicon chip for in vivo cerebral imprint in monkey.

Zaccaria A, Bouamrani A, Selek L, El Atifi M, Hesse AM, Juhem A, Ratel D, Mathieu H, Coute Y, Bruley C, Garin J, Benabid AL, Chabardes S, Piallat B, Berger F.

ACS Chem Neurosci. 2013 Mar 20;4(3):385-92. doi: 10.1021/cn300116g. Epub 2013 Jan 15.

8.

Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration.

Bilguvar K, Tyagi NK, Ozkara C, Tuysuz B, Bakircioglu M, Choi M, Delil S, Caglayan AO, Baranoski JF, Erturk O, Yalcinkaya C, Karacorlu M, Dincer A, Johnson MH, Mane S, Chandra SS, Louvi A, Boggon TJ, Lifton RP, Horwich AL, Gunel M.

Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3489-94. doi: 10.1073/pnas.1222732110. Epub 2013 Jan 28.

9.

Ubiquitin hydrolase UCH-L1 destabilizes mTOR complex 1 by antagonizing DDB1-CUL4-mediated ubiquitination of raptor.

Hussain S, Feldman AL, Das C, Ziesmer SC, Ansell SM, Galardy PJ.

Mol Cell Biol. 2013 Mar;33(6):1188-97. doi: 10.1128/MCB.01389-12. Epub 2013 Jan 7.

10.

Tracking replicability as a method of post-publication open evaluation.

Hartshorne JK, Schachner A.

Front Comput Neurosci. 2012 Mar 5;6:8. doi: 10.3389/fncom.2012.00008. eCollection 2012.

11.

Excess α-synuclein worsens disease in mice lacking ubiquitin carboxy-terminal hydrolase L1.

Shimshek DR, Schweizer T, Schmid P, van der Putten PH.

Sci Rep. 2012;2:262. doi: 10.1038/srep00262. Epub 2012 Feb 13.

12.

Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease.

Di Domenico F, Sultana R, Ferree A, Smith K, Barone E, Perluigi M, Coccia R, Pierce W, Cai J, Mancuso C, Squillace R, Wiengele M, Dalle-Donne I, Wolozin B, Butterfield DA.

Antioxid Redox Signal. 2012 Dec 1;17(11):1490-506. Epub 2012 Mar 20.

13.

Genetics of Parkinson's disease.

Gasser T.

Dialogues Clin Neurosci. 2004 Sep;6(3):295-301.

14.
15.

Postmortem studies in Parkinson's disease.

Hartmann A.

Dialogues Clin Neurosci. 2004 Sep;6(3):281-93.

16.

Common variants in PARK loci and related genes and Parkinson's disease.

Chung SJ, Armasu SM, Biernacka JM, Lesnick TG, Rider DN, Lincoln SJ, Ortolaza AI, Farrer MJ, Cunningham JM, Rocca WA, Maraganore DM.

Mov Disord. 2011 Feb 1;26(2):280-8. doi: 10.1002/mds.23376. Epub 2010 Dec 13.

17.

The UCHL1 S18Y polymorphism and Parkinson's disease in a Japanese population.

Snapinn KW, Larson EB, Kawakami H, Ujike H, Borenstein AR, Izumi Y, Kaji R, Maruyama H, Mata IF, Morino H, Oda M, Tsuang DW, Yearout D, Edwards KL, Zabetian CP.

Parkinsonism Relat Disord. 2011 Jul;17(6):473-5. doi: 10.1016/j.parkreldis.2011.01.019. Epub 2011 Feb 22.

18.

Ubiquitin carboxyl-terminal esterase L1 (UCHL1) S18Y polymorphism in patients with cataracts.

Rudolph T, Sjölander A, Palmér MS, Minthon L, Wallin A, Andreasen N, Tasa G, Juronen E, Blennow K, Zetterberg H, Zetterberg M.

Ophthalmic Genet. 2011 Jun;32(2):75-9. doi: 10.3109/13816810.2010.544360. Epub 2011 Jan 26.

19.

Transgenic animal models of neurodegeneration based on human genetic studies.

Harvey BK, Richie CT, Hoffer BJ, Airavaara M.

J Neural Transm. 2011 Jan;118(1):27-45. doi: 10.1007/s00702-010-0476-6. Epub 2010 Oct 8. Review.

20.

Ubiquitin vinyl methyl ester binding orients the misaligned active site of the ubiquitin hydrolase UCHL1 into productive conformation.

Boudreaux DA, Maiti TK, Davies CW, Das C.

Proc Natl Acad Sci U S A. 2010 May 18;107(20):9117-22. doi: 10.1073/pnas.0910870107. Epub 2010 May 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk